How Hypoxia Helps Cancer Spread | Johns Hopkins Medicine
1 天前 · Scientists at the Johns Hopkins Kimmel Cancer Center have identified 16 genes that breast cancer cells use to survive in the bloodstream after they’ve escaped the low-oxygen regions of a tumor. Each is a potential therapeutic target to stop cancer recurrence, and one – MUC1 – is already in clinical trials. The research was published online September 28 in the …
Cracking the code of DNA circles in cancer ... - Stanford Medicine
1 天前 · Those featured circles, ecDNAs, are small and often contain a few genes on their circular DNA. Frequently, these genes are cancer-associated genes called oncogenes. When a cancer cell contains multiple oncogene-encoding ecDNAs, they can supercharge the cell’s growth and allow it to evade internal checkpoints meant to regulate cell division.
Cancer News -- ScienceDaily
5 天之前 · Read the latest medical research on risk factors for cancer, cancer symptoms, treatments and more. Updated daily.
News & Events - NCI - National Cancer Institute
2024年9月16日 · The latest cancer news from the US government's principal agency for cancer research, plus resources designed for science writers and reporters.
Aggressive colon cancer: Newly identified bacteria found in ... - NBC News
A newly identified subspecies of bacteria may drive aggressive colon cancer growth. Does the bacteria play a role in the surge in cases in younger adults? Scientists discovered that a common type...
FDA approves groundbreaking treatment for advanced melanoma - NBC News
2024年2月16日 · The Food and Drug Administration on Friday approved a new cancer therapy that could one day transform the way a majority of aggressive and advanced tumors are treated.
An experimental cancer drug had a 100% success rate : NPR
2022年6月7日 · A tiny group of people with rectal cancer just experienced something of a scientific miracle: their cancer simply vanished after an experimental treatment.
Lifileucel First Cellular Therapy Approved for Cancer
2024年3月5日 · In an event more than three decades in the making, the Food and Drug Administration (FDA) has approved lifileucel (Amtagvi), the first treatment for cancer that uses immune cells called tumor-infiltrating lymphocytes, or TILs.
Cancer death rates continue to fall, driven by new ... - NBC News
2022年9月21日 · Cancer death rates continue to fall in the U.S. as new treatments are approved that use the immune system to fight cancer and screening methods improve.
A Cancer Trial’s Unexpected Result: Remission in Every Patient
2022年6月5日 · A Cancer Trial’s Unexpected Result: Remission in Every Patient. The study was small, and experts say it needs to be replicated. But for 18 people with rectal cancer, the outcome led to “happy...